Infarct Reduction Technologies develops a therapeutic device for ischemic pre-conditioning protocol. The company offers LifeCuff, a non-invasive manually-inflated blood pressure cuff for remote ischemic conditioning in heart attack, stroke, sepsis, liver surgery, traumatic brain injury, and other critical condition patients. The company is headquartered in Waldwick, New Jersey.

Ardent Pharmaceuticals, Inc. researches and develops drugs for pain, urinary incontinence, premature ejaculation, depression and cardio protection. The company is headquartered in New York, NY.

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.

Zhejiang Damei Biotechnology Co., Ltd., established on 2014-10-15, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Special Equipment Repair;Machinery and Equipment Leasing;Sales of bio-based materials;Chemical product sales(No licensed chemical products);software development;software sales;Optical communication equipment sales;Cloud Computing Equipment Technical Services;Office Supplies Sales;Research and development of bio-based materials technology;Engineering and Technology Research and Experimental Development;Mechanical equipment research and development;Medical Research and Experimental Development;Small and mini bus rental business service;Import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Ningbo Meilingsi Medical Technology Co., Ltd., established on 2012-12-11, Business scope includes general items:Engineering and Technology Research and Experimental Development;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network and Information Security Software Development;Artificial intelligence application software development;Information Technology Consulting Services;Software outsourcing service;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Wholesale of electronic components;Electronic Components Retail;electronics sales;software sales;Wearable smart device sales;Internet equipment sales;Smart home consumer device sales;IC Design(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Shenzhen Ankangyuan Technology Co., Ltd., established on 2012-05-10, Business scope includes general business items:electronic product,hardware products,plastic product,Electronic Component,Sales of instrumentation;Technology research and development of electronic products,technical consulting,Technical Services,technology transfer;Electronic product software development and sales;Domestic Trade,Import and export of goods and technology.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:electronic product,hardware products,plastic product,Electronic Component,Production of instrumentation.

Shenzhen Jinggangpai Technology Co., Ltd., established on 2013-05-03, Business scope includes general business items:Operating e-commerce;Software technology development and sales;Communication Products,digital product,electronic product,computer products,Technology development of electronic components,Sales and technical consultation;Sales of primary agricultural products;Daily Chemicals,Sales of disinfection cleaning products;Sales of Class I Medical Devices;Domestic Trade(Does not contain franchise,Exclusive control,Monopoly);Operating import and export business;Invest in business(Specific projects will be reported separately).(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:western food,coffee,drinks,Baking and selling;Health food wholesale;Pre-packaged food,Wholesale and retail of alcohol;Technology Development of Health Massage Equipment,production and sales;Class II:6820Technical development of common diagnostic equipment,production and sales;Sales of Class II Medical Devices.

Part of Adamis Pharmaceuticals Corp., DMK Pharmaceuticals Corp. is an American company. The firm operates as a clinical stage neuro biotechnology company. It was founded by Ebrahim Versi and Neil M. Frazer. Ebrahim Versi is the CEO, in this role since 2016. DMK Pharmaceuticals Corp. was acquired by Adamis Pharmaceuticals Corp. on May 25, 2023 for $27 million.\nThe company says this about itself: DMK Pharmaceuticals, Corp. is a privately held, clinical stage neuro-biotechnology company focused on developing novel therapies for opioid use disorder (OUD) and other important neuro-based conditions where patients are currently underserved. The company’s technology is at the forefront of endorphin-inspired drug design. DMK is developing mono, bi- and tri-functional small molecules that simultaneously modulate critical networks in the nervous system with the goal of creating treatments that are efficacious, safe, and tolerable. DMK has a library of high value, first-in-class compounds and a differentiated pipeline that could address several unmet medical needs by taking the novel approach to integrate with the body’s own efforts to regain balance of disrupted physiology. By designing small molecule analogs of neuropeptides, one or multiple receptors can be targeted by a single molecule to support a transition back to a balanced neurophysiological state.

Zhejiang Jianzhiyuan Biotechnology Co., Ltd., established on 2017-08-22, Business scope includes biotechnology,Biological product,medical instruments,food,Healthy food,Research on Pharmaceutical Raw Materials,to develop,technical consulting,technology transfer,Technical Services;Research and development of plant essential oils and special oils;Ganoderma lucidum,flaxseed,Camellia Seed Oil,tea seeds,Biotechnology product extraction research and development;Extraction of pure natural small molecule pectin,Production,wholesale,retail;agricultural development,Biohealth Industry Investment(Not approved by financial and other regulatory authorities,Not engage in financing deposits with the public,financing guarantee,Financial services such as wealth management on behalf of customers);Health Supplies,cosmetic,food wholesale,retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Boya Herui Technology Co., Ltd., established on 2013-03-28, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;Engineering and Technology Research and Experimental Development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada.

Suzhou Xuanyi Smart Medical Technology Co., Ltd., established on 2019-02-18, Business scope includes medical technology research and development,technology transfer,Technical Services,technical consulting,Technology Promotion;Production,Sales of medical devices(IkindIIkind);Business Management Consulting,Health Information Consultation,Health Management Consulting;Sales:electronic product,Communication Products;Software Development and Promotion,data processing;Organize cultural exchange activities,Exhibition business service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shenzhen Huayingtai Medical Co., Ltd., established on 2010-06-01, Business scope includes general business items:Research and development of biomedical technology;R & D and sales of health massage equipment and sports equipment;electronic product,Research and development of navigation and positioning application systems and software and hardware products,Sales;R&D of automation equipment,Sales;Computer hardware and software,application,Games software,Research and development, sales and technical maintenance of communication system software and hardware;Domestic Trade;Operating import and export business(above laws,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:Sales of Class II medical device products;Intelligent medical software system,Medical device product development,Production,Sales and related technical services.

Guang Zhou Zhong Long Zhi Neng Ke Ji You Xian Gong Si, established on 2017-05-03, Business scope includes artificial intelligence public service platform technical consulting services;Big data service;Software outsourcing service;Network and Information Security Software Development;IC Design;Artificial intelligence industry application system integration service;Satellite Remote Sensing Data Processing;Information system operation and maintenance services;Information Technology Consulting Services;data processing services;Computer System Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network Equipment Sales;toy sales;IoT Device Sales;Information security equipment sales;Sales of mobile terminal equipment;Sales of entertainment products and indoor amusement equipment;Cloud Computing Equipment Sales;Lighting Sales;Smart home consumer device sales;Internet information service

Guangdong General Hospital (Chinese: 广东省人民医院 meaning "Guangdong Provincial People's Hospital") is a large hospital, founded in 1946, located in Yuexiu District, Guangzhou, Guangdong, China.

Guangdong Cardiovascular Institute is a private company headquartered in Guangdong, China, that provides healthcare and surgical services.